Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Browse Other Projects on Experiment
Related Projects
Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?
Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...
Are climate change and air pollution triggering cardiovascular disease?
Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...
The Dogs of Chernobyl Research Initiative
The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...